Relay Therapeutics, Inc. financial statements
Relay Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 15.36M | 10-K |
| Net income | −USD 276.48M | 10-K |
| Cash and equivalents | USD 84.02M | 10-Q |
| Total debt | USD 32.46M | EODHD |
Relay Therapeutics, Inc. financials on 6ix · Relay Therapeutics, Inc. on 6ix